Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects
- 17 August 2024
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 41 (9) , 1-16
Abstract
Moscatilin, a bibenzyl derivative from the Dendrobium genus, has been traditionally used in Chinese medicine. Recent studies suggest its potential as a powerful anticancer agent due to its diverse pharmacological properties.This review aims to consolidate current research on moscatilin’s anticancer mechanisms, structure–activity relationships, and therapeutic potential to assess its viability for clinical use. A literature search was performed in PubMed/MedLine, Scopus, and Web of Science.The search focused on “cancer,” “moscatilin,” “anticancer,” “bioactivity,” “dendrobium,” and “pharmacological properties.” Relevant studies on molecular mechanisms, preclinical and clinical efficacy, and bioavailability were reviewed. Moscatilin exhibits significant anticancer effects in lung, breast, colorectal, and pancreatic cancers. It induces apoptosis via the JNK/SAPK pathway, inhibits cell proliferation, and suppresses metastasis. Structure–activity relationship studies reveal that phenolic groups and a two-carbon bridge are crucial for its efficacy. Additionally, moscatilin shows good bioavailability and a favorable safety profile, with low toxicity to healthy cells. Moscatilin demonstrates considerable potential as an anticancer agent, targeting multiple cancer progression pathways. Further clinical trials are essential to confirm its therapeutic efficacy and safety in humans.Keywords
This publication has 74 references indexed in Scilit:
- Identification and characterization of the metabolites of moscatilin in mouse, rat, dog, monkey and human hepatocytes by LC–Orbitrap–MS/MS combined with diagnostic fragment ions and accurate mass measurementsBiomedical Chromatography, 2022
- Rapid separation and characterization of the in vitro metabolites of moscatilin by ultra‐high performance liquid chromatography coupled to hybrid quadrupole orbitrap tandem mass spectrometryJournal of Separation Science, 2022
- Cytotoxicity and radiosensitizing potency of Moscatilin in cancer cells at low radiation doses of X-ray and UV-C3 Biotech, 2021
- Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cellsJournal of Natural Medicines, 2015
- Discrimination of the rare medicinal plant Dendrobium officinale based on naringenin, bibenzyl, and polysaccharidesScience China Life Sciences, 2012
- Moscatilin inhibits migration and metastasis of human breast cancer MDA-MB-231 cells through inhibition of Akt and Twist signaling pathwayJournal of Molecular Medicine, 2012
- Review of research on Dendrobium, a prized folk medicineApplied Microbiology and Biotechnology, 2012
- Anoikis: an emerging hallmark in health and diseasesThe Journal of Pathology, 2011
- Chemical constituents of Dendrobium aurantiacum var. denneanumChemistry of Natural Compounds, 2009
- Ramberg‐Bäcklund Rearrangement Approaches to the Synthesis of Natural BibenzylsChinese Journal of Chemistry, 2004